Quality of life (QoL) outcomes with futibatinib treatment...

Annals of Oncology 2020 / 09 Vol. 31

Quality of life (QoL) outcomes with futibatinib treatment in FOENIX-CCA2 - A phase II study in patients (pts) with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 gene fusions/rearrangements

Valle, J.W., Hollebecque, A., Furuse, J., Goyal, L., Meric-Bernstam, F., Morlock, R., He, Y., Benhadji, K., Bridgewater, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.036
Date:
September, 2020
File:
PDF, 96 KB
2020
Conversion to is in progress
Conversion to is failed